CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$45.51 +0.36 (+0.80%)
As of: Nov 11, 2026 · 12:24 PM EST

CRISPR Therapeutics AG (CRSP) Depreciation & Amortization (CF) (2015 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) posted Depreciation & Amortization (CF) of $4.24 million for Q3 2026, down 4.4% from $4.43 million a year earlier and down 1.0% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Depreciation & Amortization (CF) at CRISPR Therapeutics AG was $18.5 million, down 0.9% year-over-year; for FY2025, it came in at $19.48 million, up 1.1% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 16.2% (FY2020 to FY2025).
  • In prior years, CRISPR Therapeutics AG's Depreciation & Amortization (CF) was $19.26 million in FY2024 (-2.9%), $19.84 million in FY2023 (-17.9%), $24.17 million in FY2022 (+34.6%) and $17.95 million in FY2021 (+95.5%).
  • The Q3 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) since Q2 2021.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last three quarters, with an average decline of 2.2% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2021, with growth of 144.0%; the weakest was Q2 2023, with a decline of 31.8%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $4.28 million (Q2 2026), $4.32 million (Q1 2026) and $5.66 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 CRISPR Therapeutics AG 4.37 Bn -4.68 Bn - 4.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.24 Mn
Jun 30, 2026 4.28 Mn
Mar 31, 2026 4.32 Mn
Dec 31, 2025 5.66 Mn
Sep 30, 2025 4.43 Mn
Jun 30, 2025 4.65 Mn
Mar 31, 2025 4.74 Mn
Dec 31, 2024 4.84 Mn
Sep 30, 2024 4.74 Mn
Jun 30, 2024 4.85 Mn
Mar 31, 2024 4.83 Mn
Dec 31, 2023 4.90 Mn
Sep 30, 2023 4.93 Mn
Jun 30, 2023 4.96 Mn
Mar 31, 2023 5.05 Mn
Dec 31, 2022 5.85 Mn
Sep 30, 2022 5.02 Mn
Jun 30, 2022 7.27 Mn
Mar 31, 2022 6.04 Mn
Dec 31, 2021 6.26 Mn
API Access

CRISPR Therapeutics AG Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CRSP&period=max&api_key=YOUR_API_KEY